https://charts.traderzeitung.de/phases/US82537J1088 string(1409) "{"isin":"US82537J1088","name":"Shoulder Innovations Inc","stock_id_xnas":132476027,"stock_id_xnys":132476028,"generated_at":"2026-09-24 01:33:00","days":[{"date":"2026-09-21","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":17.52,"close_at":"2026-09-21 21:59:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-22","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":17.75,"close_at":"2026-09-22 21:58:00","complete":true,"perf_pct":1.3128},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-23","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":17.35,"close_at":"2026-09-23 21:59:00","complete":true,"perf_pct":-2.2535},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":false,"perf_pct":null}]}]}"

Shoulder Innovations Aktie News & Nachrichten

[WKN: A41EEL | Symbol: SI]

Realtimekurs

Vorbörsliche Indikationen

Regulärer Handel

Nachbörslicher Handel

10J

Alles

Artikel aus der Redaktion der Trader-Zeitung

Es konnten keine Nachrichten über Shoulder Innovations gefunden werden.

Shoulder Innovations Nachrichtenticker öffnen

MT Newswires 10.09.2026 22:35 Uhr

Shoulder Innovations Aktie News & Nachrichten

Artikel aus der Redaktion der Trader-Zeitung

Research-Alert: Shoulder Innovations erhält FDA-510(k)-Zulassung für Titanimplantat

Shoulder Innovations kooperiert mit ALM Ortho zur Einführung eines Implantats für Schulterdeformitäten

Shoulder Innovations beigelegt Patentstreit mit Catalyst OrthoScience

Shoulder Innovations-Insider verkaufte Aktien im Wert von 464.805 US-Dollar laut einer kürzlichen SEC-Meldung

--UBS passt Kursziel für Shoulder Innovations von 27 $ auf 28 $ an und behält Kaufempfehlung bei

UBS startet Bewertung von Shoulder Innovations mit Buy und einem Kursziel von 27 USD

Shoulder Innovations vereinbart Kreditfazilität von bis zu 50 Millionen US-Dollar